Radiotherapy after surgery significantly reduces atypical meningioma recurrence, international trial shows
Source Summary
An international clinical trial led in part by MedUni Vienna found that radiotherapy after complete surgical removal of atypical meningiomas significantly reduces recurrence rates. Atypical meningiomas are tumors of the meninges with high recurrence risk, and the benefit of post-surgical radiotherapy was previously unclear. The results, published in The Lancet, are expected to be incorporated into national and international treatment guidelines.
Why it matters
The trial provides clinical evidence that post-surgical radiotherapy improves outcomes for atypical meningioma patients, resolving prior uncertainty and informing treatment guidelines that will affect clinical practice.
